TrialGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2025
Health-related quality-of-life outcomes with regorafenib in advanced gastric and esophagogastric junction cancer: results from the INTEGRATE trials.
Andrew J Martin et al.PubMed ↗Publisher ↗
No numbers read from the abstract.